EMAIL THIS PAGE TO A FRIEND

Acta Biomaterialia

Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy.


PMID 25637067

Abstract

We're sorry this abstract is currently not available.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

38730 Citrate standard for IC, 1000 mg/L, analytical standard
C6H8O7
94676
Citric acid, certified reference material, TraceCERT®
C6H8O7
46933
Citric acid, analytical standard
C6H8O7
1134368
Citric acid, United States Pharmacopeia (USP) Reference Standard
C6H8O7
A1202000
Citric acid, anhydrous, European Pharmacopoeia (EP) Reference Standard
C6H8O7
PHR1071
Citric acid, Anhydrous, Pharmaceutical Secondary Standard; Certified Reference Material
C6H8O7
Y0000441
Didanosine impurity A,, European Pharmacopoeia (EP) Reference Standard
C5H4N4O
77662
Hypoxanthine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.
C5H4N4O
H9377
Hypoxanthine, ≥99.0%
C5H4N4O
H9636
Hypoxanthine, powder, BioReagent, suitable for cell culture
C5H4N4O
M1000000
Methotrexate, European Pharmacopoeia (EP) Reference Standard
C20H22N8O5
M7824
Methotrexate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, meets EP, USP testing specifications
C20H22N8O5
PHR1396
Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material
C20H22N8O5
M4010
Methotrexate, meets EP, USP testing specifications
C20H22N8O5 · xH2O
M9929
Methotrexate, meets USP testing specifications
C20H22N8O5 · xH2O
Y0000602
Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard
C20H22N8O5
Y0001668
Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard
C20H22N8O5